Comprehensive Biomarker Panels Under $100 From Leading Testing Services

A biomarker panel covering six major body systems, cardiovascular, metabolic, thyroid, hormonal, nutrient, and inflammatory, can run for a modest sum through direct-to-consumer testing, provided you know which markers to look for and how lab pricing actually works.

Order a single test through a direct-pay lab portal, and the price you pay often has nothing to do with the lab doing the work. Many of these portals route the samples through the same accredited reference labs that process blood for physicians' offices, so the test itself is identical. Not every DTC service uses the same labs or holds the same accreditation, so that equivalence doesn't apply across the board, but where it does, cost and quality are decoupled. A substantially higher price tag on one company's site and a much lower price tag on another's can reflect the exact same assay run at the exact same facility.

That gap sets up the real decision a buyer faces. A hundred dollars is roughly the point where someone can either pay for a single test through a conventional direct-pay lab, or, if they understand how the pricing actually works, walk away with a panel that covers cardiovascular, metabolic, hormonal, and inflammatory markers from one blood draw. The money spent doesn't have to shrink in scope as the price drops. It can buy six systems of data instead of one, provided the buyer knows how to shop. The choice on the table is between buying with information and buying without it, and the rest of this piece is aimed at closing that gap.

DTC Lab Pricing: Draw Fees, Membership Tiers, and All-In Cost

The sticker price on a lab test rarely matches what shows up on the card statement. Three variables separate the advertised number from the real one, and missing any of them leads to bad comparisons.

The first is the draw fee. Almost every lab charges a flat, one-time fee for the blood draw itself, on top of whatever the test costs. Order a single modestly priced test and get hit with a flat draw fee, and the test's total cost just became nearly three times the advertised price. If you order ten tests in the same draw, that same draw fee gets spread across all ten, so the added cost per marker drops to a small fraction of the original fee. The fee is charged per visit, not per test, so the math rewards ordering more at once rather than trickling tests in one at a time.

Some labs sell one test at a time, plain and simple. Others bundle testing into an annual membership or a fixed panel, which can push the per-test price down sharply but usually asks for a bigger commitment upfront. Mito Health's Essential Panel, for example, costs $89.60 at the member price, which only reflects the true cost once the membership fee behind it is factored in. Whether the membership fee gets paid back depends on the tests actually planned for the year.

The third variable is time. Advertised prices move. A number that was accurate when this article was being read may have shifted by the time an order goes through, so confirming the live price on the provider's own page before buying is a basic step, not an optional one.

One more lever belongs in this accounting: HSA and FSA funds are eligible for DTC lab tests. If you hold a qualified health savings account, you can run these purchases through pre-tax dollars, which discounts every test by whatever tax bracket applies. It's a detail plenty of buyers never think to check, and it changes the real cost of a panel more than most of the three variables above.

Once draw fees, membership structure, and current pricing are all accounted for, the all-in total for a defined panel is the fair way to compare two options, not the headline price sitting next to a single marker's name.

Which biomarkers actually belong in an affordable longevity-relevant panel

A longevity-relevant panel touches at least six biological systems: cardiovascular risk, metabolic function, thyroid, sex hormones, nutrient status, and systemic inflammation. None of the markers that cover this ground are exotic or hard to find. They're well-established tests that have simply never been bundled together at a low enough price to make sense for most buyers until recently.

Cardiovascular risk starts with the standard lipid panel, total cholesterol, LDL-C, HDL-C, and triglycerides. It's the foundation, but it stops short of the full picture. Apolipoprotein B closes that gap. ApoB counts the actual number of atherogenic particles moving through the bloodstream, which makes it a sharper read on cardiovascular risk than LDL cholesterol alone. LDL-C measures how much cholesterol is riding inside those particles, but it says nothing about how many particles are actually out there depositing that cholesterol into artery walls. Someone with small, dense LDL particles can show a deceptively normal LDL-C number while carrying a high particle count. ApoB catches what LDL-C misses. Rounding out the cardiovascular picture is hs-CRP, a marker of low-grade systemic inflammation that predicts cardiovascular events across large populations, and it carries particular weight when a risk profile looks ambiguous on lipids alone.

Metabolic function is screened through fasting glucose and HbA1c together. Both track the slow slide toward prediabetes and diabetes, a process that can run silently for years before a diagnosis ever gets made.

Thyroid status starts with TSH. A result that lands outside the optimal range is the signal to follow up with free T3 and free T4. Thyroid dysfunction ranks among the most commonly missed explanations for fatigue, unexplained weight change, and mood disruption, largely because it produces no clear symptoms until the imbalance is well underway.

Sex hormones round out the functional picture: total testosterone, estradiol, DHEA-S, and SHBG together show what a standard annual physical never captures. These systems don't operate in isolation. Insulin resistance disrupts hormonal signaling and can suppress testosterone directly, so a metabolic problem visible on a glucose panel can be the same problem appearing as a hormone imbalance three sections later.

Nutrient status deserves a place too. Vitamin D deficiency is common, and it ties to immune function, bone health, and mood. Testing it alone tends to cost more than testing it as part of a bundle, which is reason enough to fold it into a larger panel rather than ordering it on its own. A complete blood count belongs in any baseline panel as well. A CBC screens for anemia, immune abnormalities, and platelet disorders in a single test, and it may be the most information-dense single marker available at this price point.

Panels covering all six of these systems in one draw, at a modest price, do exist. The next section looks at what one of them actually includes.

Mito Health's Essential Panel at Its Member Price

The Mito Essential Panel covers all six systems above in a single blood draw, and it's priced at $89.60 for members. That price includes ApoB, a marker most entry-level panels skip.

The breakdown by system: on the heart side, Apolipoprotein B plus the standard lipid panel. For thyroid, TSH, total T4, and T3 uptake. For hormones, testosterone, estradiol, DHEA-S, and SHBG. For nutrients, you get Vitamin D, but iron is reserved for the Core tier. A complete blood count and urinalysis round out the panel.

The pricing mechanism behind that number is a membership, costing a low monthly fee, that unlocks at-cost pricing across more than a thousand biomarkers and panels. The membership fee makes the member price on the panel possible. The non-member price for the same Essential Panel runs noticeably higher, which is the clearest illustration of why the business model matters as much as the test list. Spread across a single draw with Vitamin D, a full hormone panel, and a CBC all pulled from the same visit, the fixed cost of the draw fee gets divided across far more value than it would on a single test.

Every line on the bill reflects Mito's own cost, with lab fees passed straight through and nothing padded in between. Draws happen at CLIA/CAP-accredited partner labs, including Quest, Labcorp, and BioReference locations, and most results come back within three days. The tests qualify for HSA and FSA spending as well.

Mito Health makes its money from the membership itself, not from how many tests a member orders. That incentive structure means the business has no built-in reason to push extra markers a member doesn't need. Members on Trustpilot have described the experience in terms that track with that structure, one calling it "3x the tests for less money," another describing a level of thoroughness beyond "a typical annual physical." Whether that holds for any given reader comes down to the same math laid out above: does the panel cover what you actually want to know, at a price the membership fee justifies.

Other Direct-to-Consumer Options

The broader DTC lab market offers real variety, but most alternatives at this price point ask the buyer to give something up: fewer markers covered, no clinician reviewing the results, or a draw fee structure that pushes the all-in total well past the targeted threshold once enough tests get added.

Marek Diagnostics runs an à la carte catalog of lab panels and biomarker tests sold at direct-pay prices online. That structure suits a buyer who already knows the specific marker they want and doesn't need a curated, multi-system panel built for them. The base purchase doesn't include clinician review of the results, but a healthcare provider does review and approve the test request before an order goes through. Results land directly with the buyer to interpret.

Choose Health offers at-home collection with a prepaid USPS return and delivers results electronically, and its tests qualify for HSA and FSA spending as well. Its standalone Comprehensive Metabolic Panel covers metabolic markers only, liver, kidney, electrolytes, and glucose, so it isn't built to stand in as a full longevity baseline on its own. Choose Health does sell separate thyroid, hormone, adrenal, and lipid panels alongside that CMP, and its Comprehensive GLP-1 Panel adds ApoB, a full lipid panel, and TSH into one order. For someone tracking metabolic markers specifically, that's a reasonable fit. For someone trying to cover six systems in a single draw the way the Essential Panel does, it takes stitching several separate orders together.

That points to the structural pattern running through this entire market: a low per-test price only pays off once a draw fee gets spread across enough markers in a single visit. A service selling tests one at a time can look cheaper on a per-marker basis and still cost more once a buyer assembles the same six-system coverage, because each separate order resets the draw fee. The only honest comparison is the all-in total for the panel a buyer actually wants, not the price next to any single line item.

The markers most panels leave out at this price point, and whether they matter

A handful of markers with strong longevity evidence behind them sit just outside most entry-level panels, including the Essential tier. Whether it's worth adding one marker individually or moving up to a broader panel depends on which ones apply to a given buyer's situation.

Fasting insulin doesn't appear in a standard CMP or in an HbA1c-only panel, but it catches insulin resistance years before glucose numbers start trending into diagnostic territory. Insulin resistance drives hormonal disruption, systemic inflammation, and cardiovascular risk all at once, so catching it through fasting insulin gives a buyer a head start that waiting on HbA1c simply doesn't. It shows up in Mito's Core panel tier, one step above Essential.

Homocysteine carries real weight for cardiovascular and cognitive risk, but primary care rarely orders it by default, and you won't find it in standard lipid or metabolic panels.

Lp(a) is a genetically determined cardiovascular risk marker that doesn't move with diet or exercise. Lifestyle change won't lower it, so testing it once still carries clinical value, because the number itself rarely changes again. It's included in Mito's Core tier.

Free T3 and free T4 add resolution that TSH alone can't give you, because TSH by itself can miss subclinical thyroid dysfunction. Both appear in Mito's Core tier as well.

Ferritin, a measure of iron stores, gets missed by a standard CBC despite driving energy levels directly. Low ferritin often underlies unexplained fatigue and poor exercise tolerance, even when every other blood marker looks normal.

What ties these five markers together is timing. A longevity-focused panel is built to catch dysfunction before it becomes disease: insulin resistance years ahead of a diabetes diagnosis, arterial damage before a cardiac event, hormonal decline before symptoms force a doctor's visit. These are the markers that supply that earlier warning.

There's a practical rule for deciding whether any of them are worth paying for. If the Essential panel comes back with a flag in a given system, that result itself points toward the next test. An ApoB elevation is a reason to add Lp(a) and look harder at cardiovascular risk. A borderline HbA1c is a reason to check fasting insulin rather than wait a year for the next annual draw. Clinician-reviewed interpretation matters here too: optimal ranges for preventive health often sit narrower than the standard reference ranges used in routine clinical care, and understanding what a given number means for a specific person's biology is often as valuable as the test result itself.